mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.7 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |